Baldwin Pharmaceuticals Private Limited
About Baldwin Pharmaceuticals Private Limited
Data last updated:
Baldwin Pharmaceuticals Private Limited is a private limited company based in Jammu, Jammu And Kashmir, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U52100JK2015PTC004504. Its GSTIN is 01AAGCB4305G1ZD (Jammu and Kashmir).
The company has an authorised share capital of ₹8 Lakh and a paid-up capital of ₹8 Lakh. It is led by directors including Preeti Gupta and Vipen Kumar Mahajan.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at H No 105 Lano No 16 Talab Tillo Jammu (J&K), Jammu and Kashmir, India – 180002.
As per the financials filed for FY 2022, the company reported a revenue of ₹31,063, a decline of 58% compared to the previous year. For the same year it recorded a net loss of ₹6.84 Lakh and EBITDA of ₹28,563 (EBITDA margin 92%). Revenue has declined at a compounded annual rate (CAGR) of 70% over three years and 59% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh and satisfied charges of ₹11 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH No 105 Lano No 16 Talab Tillo Jammu (J&K), Jammu and Kashmir, India – 180002
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Baldwin Pharmaceuticals Private Limited
The main business activity of Baldwin Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Baldwin Pharmaceuticals Private Limited FY 2022 filings available
Baldwin Pharmaceuticals Private Limited reported revenue of ₹31,063 (down 58% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Baldwin Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 59% over five years, including a 58% fall in the latest year. EBITDA fell 60% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Baldwin Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹28,563 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.84 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Baldwin Pharmaceuticals Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 92% | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Baldwin Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Baldwin Pharmaceuticals Private Limited
Baldwin Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Preeti Gupta | Director | 22 Sep 2015 | 11 Years 0 Months | Current |
| Vipen Kumar Mahajan | Director | 22 Sep 2015 | 11 Years 0 Months | Current |
| Simranjeet Singh | Director | 22 Sep 2015 | 11 Years 0 Months | Current |
Peer Comparison of Baldwin Pharmaceuticals Private Limited
Baldwin Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Papez Pharmaceuticals Private Limited | ₹31,856 (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Deepvin Pharmaceuticals Private Limited | ₹31,729 (FY 2024) | •••• | •••• | -82.0% | •••• | Lucknow, Uttar Pradesh, India |
| Indoor Biotechnologies India Private Limited | ₹31,480 (FY 2023) | •••• | •••• | -100.0% | •••• | Bangalore, Karnataka, India |
| Akaal Life Sciences Private Limited | ₹31,157 (FY 2025) | •••• | •••• | -14.0% | •••• | Mohali, Punjab, India |
| Neopower Pharmaceuticals Private Limited | ₹31,100 (FY 2024) | •••• | •••• | -93.0% | •••• | Hazaribagh, Jharkhand, India |
| Baldwin Pharmaceuticals Private Limited this company | ₹31,063 (FY 2022) | •••• | •••• | -58.0% | •••• | Jammu, Jammu And Kashmir, India |
| Marshall Hospital Private Limited | ₹31,022 (FY 2025) | •••• | •••• | -93.0% | •••• | New Delhi, Delhi, India |
| Sunvill Healthcare Private Limited | ₹31,000 (FY 2023) | •••• | •••• | •••• | Baddi, Himachal Pradesh, India | |
| Kingbuild Pharmaceuticals Private Limited | ₹30,800 (FY 2021) | •••• | •••• | -52.0% | •••• | Surat, Gujarat, India |
| Apg Needles Pvt Ltd | ₹30,738 (FY 2024) | •••• | •••• | -100.0% | •••• | New Delhi, Delhi, India |
| Petula Pharmaceuticals Private Limited | ₹30,500 (FY 2024) | •••• | •••• | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Baldwin Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Baldwin Pharmaceuticals Private Limited
Baldwin Pharmaceuticals Private Limited is audited by KRISHAN P GUPTA & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| KRISHAN P GUPTA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Baldwin Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Baldwin Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2016 | Others | ₹40 Lakh | Open |
| 19 Jan 2016 | The Jammu and Kashmir Bank Limited | ₹11 Lakh | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Baldwin Pharmaceuticals Private Limited
Baldwin Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Baldwin Pharmaceuticals. All case is disposed. Status as checked on 29 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Jammu and Kashmir and Ladakh | Writ petition | Filed by the company against Union of India Th Secretary Ministry of Finance Govt of India | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Baldwin Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Baldwin Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Baldwin Pharmaceuticals Private Limited
Baldwin Pharmaceuticals Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Sahil Mahajan ceased to be Managing Director on 01 Jan 2022.
Credit Ratings, Litigation & Regulatory Alerts for Baldwin Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Baldwin Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Baldwin Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Baldwin Pharmaceuticals Private Limited
Baldwin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01AAGCB4305G1ZD | Jammu and Kashmir | Active | 08 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Baldwin Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Baldwin Pharmaceuticals Private Limited
Baldwin Pharmaceuticals is an active private limited company based in Jammu, Jammu And Kashmir, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 September 2015 (11+ years old) and is registered under CIN U52100JK2015PTC004504.
Baldwin Pharmaceuticals reported revenue of ₹31,063 for FY 2022 (down 58% YoY).
Baldwin Pharmaceuticals has 3 current directors:
- Preeti Gupta - Director
- Vipen Kumar Mahajan - Director
- Simranjeet Singh - Director
Baldwin Pharmaceuticals reported a net loss of ₹6.84 Lakh and EBITDA of ₹28,563 (EBITDA margin 92%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Baldwin Pharmaceuticals is -70% over three years and -59% over five years. In the latest year (FY 2022) revenue fell 58%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Baldwin Pharmaceuticals is 01AAGCB4305G1ZD, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Baldwin Pharmaceuticals is U52100JK2015PTC004504. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Baldwin Pharmaceuticals has 1 court case on record: 1 filed by the company.
Baldwin Pharmaceuticals was incorporated on 22 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of Baldwin Pharmaceuticals by revenue are Papez Pharmaceuticals Private Limited, Deepvin Pharmaceuticals Private Limited, Indoor Biotechnologies India Private Limited, Akaal Life Sciences Private Limited, Neopower Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Sahil Mahajan ceased to be Managing Director on 01 Jan 2022. Preeti Gupta was appointed as Director on 22 Sep 2015. Simranjeet Singh was appointed as Director on 22 Sep 2015. Baldwin Pharmaceuticals has 4 board changes on record in total.